Nathan Yumibe

1.6k total citations
30 papers, 1.1k citations indexed

About

Nathan Yumibe is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Nathan Yumibe has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Organic Chemistry and 9 papers in Pharmacology. Recurrent topics in Nathan Yumibe's work include Pharmacogenetics and Drug Metabolism (9 papers), Peroxisome Proliferator-Activated Receptors (7 papers) and Drug Transport and Resistance Mechanisms (6 papers). Nathan Yumibe is often cited by papers focused on Pharmacogenetics and Drug Metabolism (9 papers), Peroxisome Proliferator-Activated Receptors (7 papers) and Drug Transport and Resistance Mechanisms (6 papers). Nathan Yumibe collaborates with scholars based in United States, United Kingdom and China. Nathan Yumibe's co-authors include Harry R. Davis, John W. Clader, Stuart B. Rosenblum, Adriano Afonso, Duane A. Burnett, Tram Huynh, Douglas S. Compton, Margaret van Heek, Keith Huie and Robbie L. McLeod and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Nathan Yumibe

30 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nathan Yumibe United States	18	413	354	289	165	137	30	1.1k
Steven M. Pitzenberger United States	20	418 1.0×	609 1.7×	145 0.5×	151 0.9×	64 0.5×	49	1.5k
Toshiaki Nakashima Japan	21	353 0.9×	525 1.5×	144 0.5×	211 1.3×	46 0.3×	69	1.6k
Roger B. Ruggeri United States	24	1.1k 2.7×	815 2.3×	442 1.5×	163 1.0×	144 1.1×	43	2.2k
Drago R. Sliskovic United States	19	468 1.1×	617 1.7×	575 2.0×	205 1.2×	293 2.1×	46	1.6k
Johannes D. Aebi Switzerland	24	606 1.5×	1.1k 3.0×	162 0.6×	93 0.6×	121 0.9×	40	1.6k
Weiren Xu China	22	332 0.8×	902 2.5×	187 0.6×	315 1.9×	40 0.3×	98	1.5k
Hisashi Shinkai Japan	14	291 0.7×	573 1.6×	498 1.7×	112 0.7×	158 1.2×	27	1.6k
James R. Tata United States	21	606 1.5×	637 1.8×	184 0.6×	76 0.5×	55 0.4×	62	1.7k
Soumya P. Sahoo United States	19	433 1.0×	511 1.4×	184 0.6×	286 1.7×	62 0.5×	31	1.1k

Countries citing papers authored by Nathan Yumibe

Since Specialization

Citations

This map shows the geographic impact of Nathan Yumibe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathan Yumibe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathan Yumibe more than expected).

Fields of papers citing papers by Nathan Yumibe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nathan Yumibe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathan Yumibe. The network helps show where Nathan Yumibe may publish in the future.

Co-authorship network of co-authors of Nathan Yumibe

This figure shows the co-authorship network connecting the top 25 collaborators of Nathan Yumibe. A scholar is included among the top collaborators of Nathan Yumibe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nathan Yumibe. Nathan Yumibe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yumibe, Nathan, Zhongyi Wang, Xin Zhang, et al.. (2012). Comparative Pharmacokinetics Studies of Immediate- and Modified-Release Formulations of Glipizide in Pigs and Dogs. Journal of Pharmaceutical Sciences. 101(11). 4327–4336. 10 indexed citations

Recknor, Justin, et al.. (2008). Fabp3 as a Biomarker of Skeletal Muscle Toxicity in the Rat: Comparison with Conventional Biomarkers. Toxicological Sciences. 103(2). 382–396. 38 indexed citations

Shi, Qing, Yanping Xu, Alan M. Warshawsky, et al.. (2007). Design and synthesis of novel and potent amide linked PPARγ/δ dual agonists. Bioorganic & Medicinal Chemistry Letters. 17(24). 6744–6749. 4 indexed citations

Henry, James R., Yihong Li, Alan M. Warshawsky, et al.. (2006). Tetrahydroisoquinoline PPARγ agonists: Design of novel, highly selective non-TZD antihyperglycemic agents. Bioorganic & Medicinal Chemistry Letters. 16(24). 6293–6297. 1 indexed citations

González, Isabel Chirivella, Yanping Xu, Leonard L. Winneroski, et al.. (2006). Design and synthesis of a novel class of dual PPARγ/δ agonists. Bioorganic & Medicinal Chemistry Letters. 17(4). 1052–1055. 19 indexed citations

Victor, Frantz, Robert B. Johnson, John I. Glass, et al.. (2004). P4 and P1′ optimization of bicycloproline P2 bearing tetrapeptidyl α-ketoamides as HCV protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(19). 5007–5011. 30 indexed citations

Victor, Frantz, Nancy Snyder, Nathan Yumibe, et al.. (2003). P1 and P3 optimization of novel bicycloproline P2 bearing tetrapeptidyl α-ketoamide based HCV protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 14(1). 257–261. 26 indexed citations

Xu, Yanping, Xiaodong Wang, R. C. Thompson, et al.. (2003). Design and Synthesis of a Potent and Selective Triazolone-Based Peroxisome Proliferator-Activated Receptor α Agonist. Journal of Medicinal Chemistry. 46(24). 5121–5124. 52 indexed citations

Victor, Frantz, Robert B. Johnson, John I. Glass, et al.. (2003). Discovery of a novel bicycloproline P2 bearing peptidyl α-ketoamide LY514962 as HCV protease inhibitor. Bioorganic & Medicinal Chemistry Letters. 14(1). 251–256. 38 indexed citations

10.

Michellys, Pierre‐Yves, Marcus F. Boehm, Timothy A. Grese, et al.. (2003). Design and synthesis of novel RXR-selective modulators with improved pharmacological profile. Bioorganic & Medicinal Chemistry Letters. 13(22). 4071–4075. 21 indexed citations

11.

Gernert, Douglas L., Rose T. Ajamie, Mike Bell, et al.. (2003). Design and synthesis of fluorinated RXR modulators. Bioorganic & Medicinal Chemistry Letters. 13(19). 3191–3195. 16 indexed citations

12.

McKittrick, Brian A., Ke Ma, Keith Huie, et al.. (1998). ChemInform Abstract: Synthesis of C3 Heteroatom‐Substituted Azetidinones That Display Potent Cholesterol Absorption Inhibitory Activity.. ChemInform. 29(27). 1 indexed citations

13.

Heek, Margaret van, Douglas S. Compton, Robbie L. McLeod, et al.. (1997). In Vivo Metabolism-Based Discovery of a Potent Cholesterol Absorption Inhibitor, SCH58235, in the Rat and Rhesus Monkey through the Identification of the Active Metabolites of SCH48461. Journal of Pharmacology and Experimental Therapeutics. 283(1). 157–163. 240 indexed citations

14.

Yumibe, Nathan, et al.. (1996). Identification of human liver cytochrome P450 enzymes that metabolize the nonsedating antihistamine loratadine. Biochemical Pharmacology. 51(2). 165–172. 89 indexed citations

15.

Kirkup, Michael P., Razia Rizvi, Sundeep Dugar, et al.. (1996). ChemInform Abstract: (‐)‐SCH 57939: Synthesis and Pharmacological Properties of a Potent, Metabolically Stable Cholesterol Absorption Inhibitor.. ChemInform. 27(52). 3 indexed citations

16.

Kirkup, Michael P., Razia Rizvi, Bandarpalle B. Shankar, et al.. (1996). (−)-SCH 57939: synthesis and pharmacological properties of a potent, metabolically stable cholesterol absorption inhibitor. Bioorganic & Medicinal Chemistry Letters. 6(17). 2069–2072. 20 indexed citations

17.

Yumibe, Nathan, et al.. (1995). Identification of Human Liver Cytochrome P450s Involved in the Microsomal Metabolism of the Antihistaminic Drug Loratadine. International Archives of Allergy and Immunology. 107(1-3). 420–420. 28 indexed citations

18.

Thompson, John A. & Nathan Yumibe. (1989). Mechanistic Aspects of Cytochrome P450-Hydroperoxide Interactions: Substituent Effects on Degradative Pathways. Drug Metabolism Reviews. 20(2-4). 365–378. 14 indexed citations

19.

Yumibe, Nathan, et al.. (1988). Fate of free radicals generated during one-electron reductions of 4-alkyl-1,4-peroxyquinols by cytochrome P 450. Chemical Research in Toxicology. 1(6). 385–390. 6 indexed citations

20.

Nelsen, Stephen F., Silas C. Blackstock, Nathan Yumibe, et al.. (1985). Syn and anti bent hydrazine radical cations. Effect of .sigma.,.pi. mixing on spectral properties. Journal of the American Chemical Society. 107(1). 143–149. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact